Matteo ColomboIntroduction As we slowly (or rapidly?) head toward 2024, it's time to discuss one of the most fascinating stocks of 2023. This year, I started covering Agilent Technologies (NYSE:A) as part of a bigger focus on the healthcare sector. My most recent coverage was published on November 17, when I wrote an article titled "Agilent Technologies: Looking Undervalued Heading Into Earnings." As the title may suggest, it was an earnings preview in light of the stock's poor performance. Here's a pa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________ Form 10-K _____________________________________________________________ (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended October 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001-15405 _____ ...

Agilent Technologies, Inc. (NYSE:A) Evercore ISI HealthCONx Conference 2023 November 29, 2023 10:50 AM ET Company Participants Mike McMullen - President and Chief Executive Officer Bob McMahon - Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Vijay Kumar Thanks everyone for joining us this morning. I’m Vijay Kumar. I cover Life Science and MedTech here at Evercore. Pleasure to have with us, Agilent Technologies this morning. From the company we have CEO, Mike McMullen; CFO, B ...

Agilent Technologies Q4’23 Financial Results Overview Safe Harbor These presentations contain forward-looking statements (including, without limitation, information, and future guidance on the company’s goals, priorities, revenue, revenue growth, earnings per share, operating margin, operating cash flow, capital expenditures, capital allocation, growth opportunities, new products and solutions, customer service and innovation plans, financial condition and considerations, impact of acquisitions, share repur ...

Agilent Technologies, Inc. (NYSE:A) Q4 2023 Earnings Conference Call November 20, 2023 4:30 PM ET Company Participants Parmeet Ahuja - IR Mike McMullen - President and CEO Robert McMahon - SVP and CFO Sam Raha - President, Agilent Diagnostics & Genomics Group Padraig McDonnell - President, Agilent CrossLab Group Phil Binns - President of the Agilent Life Sciences and Applied Markets Group Conference Call Participants Vijay Kumar - Evercore ISI Patrick Donnelly - Citigroup Inc. Matt Sykes - Goldman Sachs Ra ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended July 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001-15405 AGILENT TECHNOLOGIES, INC. (Exact Name of registrant as specified in its charter) Delaware 77-0518772 (State or other jurisd ...

Agilent Technologies, Inc. (NYSE:A) Q3 2023 Earnings Conference Call August 15, 2023 4:30 PM ET Company Participants Parmeet Ahuja - IR Mike McMullen - President and CEO Robert McMahon - SVP and CFO Padraig McDonnell - President, Agilent CrossLab Group Sam Raha - President, Agilent Diagnostics & Genomics Group Jacob Thaysen - President, Agilent Life Science & Applied Markets Group Conference Call Participants Matt Sykes - Goldman Sachs Jack Meehan - Nephron Research Vijay Kumar - Evercore ISI Dan Leonard - ...

Agilent Technologies Q3’23 Financial Results Overview Safe Harbor These presentations contain forward-looking statements (including, without limitation, information, and future guidance on the company’s goals, priorities, revenue, revenue growth, earnings per share, operating margin, operating cash flow, capital expenditures, capital allocation, growth opportunities, new products and solutions, customer service and innovation plans, financial condition and considerations, impact of acquisitions, share repur ...

Agilent Technologies, Inc. (NYSE:A) Jefferies Global Healthcare Conference June 7, 2023 9:00 AM ET Company Participants Mike McMullen - Chief Executive Officer Bob McMahon - Chief Financial Officer Conference Call Participants Brandon Couillard - Jefferies Brandon Couillard Welcome to the Jefferies 2023 New York Global Healthcare conference. Very happy to have Agilent with us at the conference today. Joining us, CEO, as most of you probably know, Mike McMullen; as well as CFO, Bob McMahon. Thanks, everybody ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended April 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001-15405 AGILENT TECHNOLOGIES, INC. (Exact Name of registrant as specified in its charter) Delaware 77-0518772 (State or other juris ...